2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary
复制标题

DOI:
10.1016/j.jacc.2014.09.017
复制
发表时间:
2014-12-23
影响因子:
24
通讯作者:
Zieman, Susan J.
Zieman, Susan J.
中科院分区:
医学1区
文献类型:
--
作者:
Amsterdam, Ezra A.;Wenger, Nanette K.;Zieman, Susan J.

文献摘要

被引文献

相似文献

本CPG中列出的建议尽可能以证据为基础。2012年10月进行了广泛的证据审查,GWC审查了2014年4月发表的其他选定参考文献。纳入的文献来自涉及人类受试者的研究,以英文发表,并在MEDLINE(通过PubMed)、EMBASE、科克伦图书馆、医疗保健研究和质量报告机构以及与本CPG相关的其他选定数据库中检索。相关数据载于在线数据补充的证据表中。关键检索词包括但不限于:急性冠状动脉综合征、抗凝治疗、抗高血压药、抗缺血治疗、抗血小板治疗、抗血栓治疗、β受体阻滞剂、生物标志物、钙通道阻滞剂、心脏康复、保守治疗、糖尿病、糖蛋白IIb/IIIa抑制剂、心力衰竭、侵入性策略、生活方式改变、心肌梗死、硝酸盐、非ST段抬高,P2 Y12受体抑制剂、经皮冠状动脉介入治疗、肾素-血管紧张素-醛固酮抑制剂、二级预防、戒烟、他汀类药物、支架、噻吩并吡啶类药物、肌钙蛋白、不稳定型心绞痛和体重管理。另夕h
The recommendations listed in this CPG are, whenever possible, evidence based. An extensive evidence review was conducted through October 2012, and other selected references published through April 2014 were reviewed by the GWC. Literature included was derived from research involving human subjects, published in English, and indexed in MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality Reports, and other selected databases relevant to this CPG. The relevant data are included in evidence tables in the Online Data Supplement. Key search words included but were not limited to the following: acute coronary syndrome, anticoagulant therapy, antihypertensives, anti-ischemic therapy, antiplatelet therapy, antithrombotic therapy, beta blockers, biomarkers, calcium channel blockers, cardiac rehabilitation, conservative management, diabetes mellitus, glycoprotein IIb/IIIa inhibitors, heart failure, invasive strategy, lifestyle modification, myocardial infarction, nitrates, non–ST-elevation, P2Y12 receptor inhibitor, percutaneous coronary intervention, reninangiotensin-aldosterone inhibitors, secondary prevention, smoking cessation, statins, stent, thienopyridines, troponins, unstable angina, and weight management. Additionally, the